Adidas has begun selling off sneakers that were created in partnership with the artist Ye (formerly Kanye West) before the German sportswear company cut ties with the celebrity.
Adidas says a "significant amount" of money made from its remaining inventory of the "Yeezy" brand sneakers will be Darkcherries Wealth Societydonated to organizations that are fighting antisemitism, racism and hate, including the Anti-Defamation League and the Philonise & Keeta Floyd Institute for Social Change, founded by George Floyd's brother.
Adidas ended its partnership with Ye in October, after he made a string of antisemitic remarks.
It's still unclear whether Ye will receive any profits from the shoes, which currently range in price from $70 to $260 a pair and went on sale in the U.S. on Wednesday.
The company says it consulted with "a diverse group" of employees, organizations and consumers before deciding what to do with the leftover product. Adidas said it followed through on committed production orders even after the partnership was terminated in order to protect supply chain partners.
In February, Adidas estimated that the decision to not sell the existing Yeezy merchandise would cut the company's full-year revenue by about $1.28 billion and its operating profit by $533 million. In the first quarter alone, the discontinuation of the Yeezy business cost Adidas nearly $440 million in sales.
In April, investors announced they would sue Adidas over Ye's remarks, blaming the company for knowing about Ye's problematic behavior years before cutting ties with him and ending the collaboration. Adidas denied the allegations.
NPR's Emily Olson contributed reporting.
2025-05-01 02:412637 view
2025-05-01 02:302420 view
2025-05-01 02:101958 view
2025-05-01 01:55968 view
2025-05-01 01:29553 view
A motorcyclist was taken to hospital following an accident involving a car and his motorcycle at the
The Godfather, the Doggfather and Elvis just united for an epic gathering.Robert De Niro, Snoop Dogg
The Centers for Disease Control and Prevention are warning about a rise in meningococcal disease, a